Cartilage organoids: an emerging platform for novel osteoarthritis therapies
Frontiers in Cell and Developmental Biology · 12.12.2025 · 13
DOI: 10.3389/fcell.2025.1668766 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 12.12.2025. Verfasst von Bimin Gao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Orthopaedic Innovation Laboratory, Shenzhen Nanshan People's Hospital, The Affiliated Nanshan Hospital of Shenzhen University, Shenzhen, Guangdong, C…. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 147 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Osteoarthritis (OA) is a chronic, multifactorial joint disorder characterized by the progressive degeneration and dysfunction of various joint tissues. Current treatments primarily focus on symptom management, offering limited success in halting cartilage degradation or repairing damaged tissues. Consequently, there is a pressing need for innovative therapeutic strategies aimed at cartilage regeneration and structural repair. Over the past 2 decades, cartilage organoids have emerged as a promising alternative for OA treatment. Due to their unique regenerative properties, cartilage organoids provide a versatile platform for various applications in OA research and therapy, including in vitro disease modeling, drug screening, regenerative medicine, and biomechanical studies. This review summarizes current research progress and insights into OA pathogenesis and therapeutic approaches, explores the development of cartilage organoid technologies with a focus on organoid constructions and different methodologies, and discusses the future applications of cartilage organoids as essential in vitro models for drug screening and personalized therapies for OA studies and treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Orthopaedic Innovation Laboratory, Shenzhen Nanshan People's Hospital, The Affiliated Nanshan Hospital of Shenzhen University, Shenzhen, Guangdong, China.
- Department of Osteoarthropathy, Shenzhen Nanshan People's Hospital, Shenzhen, Guangdong, China.
- Department of Spine Surgery, Shenzhen Nanshan People's Hospital, Shenzhen, Guangdong, China.
- Department of Orthopaedics and Rehabilitation, Yale University School of Medicine, New Haven, CT, United States.
- Department of Biochemistry, Homeostatic Medicine Institute, School of Medicine, Guangdong Provincial Key Laboratory of Cell Microenvironment and Disease Research, Shenzhen Key Laboratory of Cell Microenvironment, Southe…
Zitieren
APA
Gao, B., Chen, Z., Long, Y., He, F., Gan, D., Yi, W., Xiao, G., Ren, J., & Qin, L. (2025). Cartilage organoids: an emerging platform for novel osteoarthritis therapies. Frontiers in Cell and Developmental Biology, 13. https://doi.org/10.3389/fcell.2025.1668766
Vancouver
Gao B, Chen Z, Long Y, He F, Gan D, Yi W, et al. Cartilage organoids: an emerging platform for novel osteoarthritis therapies. Frontiers in Cell and Developmental Biology. 2025;13. doi:10.3389/fcell.2025.1668766
BibTeX
@article{Gao2025,
author = {Gao, Bimin and Chen, Zecai and Long, Yufeng and He, Feng and Gan, Donghao and Yi, Weihong and Xiao, Guozhi and Ren, Jiangdong and Qin, Lei},
title = {Cartilage organoids: an emerging platform for novel osteoarthritis therapies},
journal = {Frontiers in Cell and Developmental Biology},
year = {2025},
volume = {13},
doi = {10.3389/fcell.2025.1668766}
}
EUVIMED